Related Experiment Video
Updated: Sep 6, 2025

07:24
Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
Published on: February 10, 2023
1.6K
Mitochondrial disease caused by the m.3243A>G mutation
Kristin N Varhaug1, Omar Hikmat2, Laurence A Bindoff1
1Nevrologisk avdeling, Haukeland universitetssjukehus, og, Klinisk institutt 1, Universitetet i Bergen.
Summary
Mitochondrial disease, a common metabolic disorder, is often caused by the m.3243A>G mutation. Understanding this mutation improves diagnosis and treatment for patients with this serious condition.
Area of Science:
- Genetics
- Metabolic Disorders
- Neurology
Background:
- Mitochondrial disease is a prevalent group of metabolic disorders affecting multiple organ systems.
- The m.3243A>G mutation is a frequent genetic cause of mitochondrial disease.
- This mutation has significant implications across various medical specialties.
Purpose of the Study:
- To review the clinical aspects of mitochondrial disease.
- To focus on the m.3243A>G mutation and its associated clinical manifestations.
- To emphasize the importance of knowledge for improved patient care.
Main Methods:
- This is a clinical review article.
- It synthesizes existing knowledge on the m.3243A>G mutation and its effects.
- No new experimental data were generated.
Main Results:
- The m.3243A>G mutation can lead to a wide spectrum of symptoms.
- Commonly associated conditions include diabetes mellitus, hearing loss, cardiac and muscle issues, encephalopathy, epilepsy, gastrointestinal problems, and visual impairment.
- These symptoms often occur in combination, presenting complex clinical pictures.
Conclusions:
- Enhanced understanding of the m.3243A>G mutation is crucial for effective management.
- Improved diagnostic and therapeutic strategies can benefit patients with this mitochondrial disease.
- Early recognition and comprehensive care are vital for this life-threatening condition.
More Related Videos
Related Concept Videos
Animal Mitochondrial Genetics
8.0K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
8.0K
Translation
143.2K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
143.2K
ATP Synthase: Mechanism
15.1K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
15.1K
Translocation of Proteins into the Mitochondria
3.2K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.2K
Mitochondrial Precursor Proteins
2.6K
Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70 chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...
Most of the mitochondrial...
2.6K
Inborn Errors of Metabolism
237
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
237

